IQVIA Holdings (BSP:I1QV34) Gross-Profit-to-Asset % : 21.04% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is IQVIA Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. IQVIA Holdings's annualized Gross Profit for the quarter that ended in Dec. 2023 was R$27,243 Mil. IQVIA Holdings's average Total Assets over the quarter that ended in Dec. 2023 was R$129,512 Mil. Therefore, IQVIA Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 21.04%.

IQVIA Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for IQVIA Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Gross-Profit-to-Asset % Chart

IQVIA Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

16.99

17.90

19.73

19.36

19.47

IQVIA Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															21.50	19.57	19.16	20.32	21.04

Competitive Comparison of IQVIA Holdings's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, IQVIA Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IQVIA Holdings's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Gross-Profit-to-Asset % falls into.

IQVIA Holdings Gross-Profit-to-Asset % Calculation

IQVIA Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	25670.052	/	( (132902.7	+	130731.564)	/ 2 )
	=	25670.052	/	131817.132
	=	19.47 %

IQVIA Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	27242.888	/	( (128292.61	+	130731.564)	/ 2 )
	=	27242.888	/	129512.087
	=	21.04 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

IQVIA Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings (BSP:I1QV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (BSP:I1QV34) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

IQV:USA IQV:Mexico QTS:Germany QTS:Germany

Address

2400 Ellis Road, Durham, NC, USA, 27703

Website

https://www.iqvia.com

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings (BSP:I1QV34) Headlines

No Headlines